Limited Coverage Drugs - Secukinumab

Generic Name



150 mg


Solution for subcutaneous injection                                             

Special Authority Criteria

Approval Period

Treatment of moderate to severe Plaque Psoriasis, according to established criteria*, when prescribed by a dermatologist.

First approval: 12 weeks
Renewal: 1 year

* For the full criteria, see the relevant Special Authority Form below.

Practitioner Exemptions

  • None

Special Notes

  • PharmaCare covers a maximum of 30 days per fill for secukinumab.

Special Authority Request Form(s)